Will Eli Lilly's new weight loss drug Zepbound sell >$2B in the US by 2025? (first full year on the market)
4
21
Ṁ80Ṁ110
2025
72%
chance
1D
1W
1M
ALL
This market will resolve to YES if Zepbound has sold at least $2 billion in the US after its first 4 full quarters on the market. The evaluation criteria will be Eli Lilly's Annual Report for FY 2024. This is expected to be available in February 2025.
Get Ṁ200 play money
Related questions
Will a GLP-1 agonist diabetes / weight loss drug be the top bestselling drug in 2025?
31% chance
Will Medicare or Medicaid cover weight loss drugs by 2029?
76% chance
Will a publicly listed pharma company reach $1T in market cap before 2025?
51% chance
Will GLP-1 agonists help stop or reverse the US obesity trend by end of 2027
73% chance
More than 10% of US citizens will be on prescription drugs for weight loss by 2031
59% chance
Will a drug to be used by most healthy adults be approved by 2043 year end?
63% chance
Will at least one new hair loss treatment which is more effective than existing treatments become approved by the FDA and publicly available by 2025?
17% chance
Will there be medical consensus that GLP-1 drugs have cardiovascular benefits beyond those provided via weight loss?
66% chance
Will 10 million Americans be on semaglutide (or yet-to-be-approved equally good or superior alternatives) by the end of 2030?
73% chance
More than 30% of US citizens will be on prescription drugs for weight loss by 2031
19% chance